To include your compound in the COVID-19 Resource Center, submit it here.
Cell therapy company SQZ Biotechnologies Co. (Watertown, Mass.) raised $72 million on Aug. 8 in an oversubscribed, untranched
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury